Celine Galvagnion

University of Copenhagen, Department of Drug Design and Pharmacology (ILF), is advertising a 3-year postdoctoral position in lipidomics starting from February 2027 . The project is centered on developing analytical methods to identify and quantify gangliosides and glucosylsphingosine , and integrating these approaches with existing methods at the Lipidomics Core Facility at the Danish Cancer Institute . The research will analyze samples from people with Parkinson’s disease to identify lipid changes associated with disease pathology. This is a collaborative project involving Celine Galvagnion (Associate Professor, University of Copenhagen), together with Mesut Bilgin and Kenji Maeda at the Danish Cancer Institute. The postdoc is part of a 5-year Hallas-Møller Ascending Investigator project supported by the Novo Nordisk Foundation . Location: University of Copenhagen, Denmark. Deadline: 15 November 2026, 23:59 CET. Research keywords: lipidomics, Parkinson’s disease, gangliosides, glucosylsphingosine, analytical chemistry, neurodegeneration, biomarker discovery. Applicants interested in postdoctoral research in lipidomics, neurodegenerative disease, and analytical method development should review the vacancy page and submit their application before the deadline.